Profile data is unavailable for this security.
About the company
Bellevue Healthcare Trust plc is a United Kingdom-based investment trust. The investment objective of the Company is to provide Shareholders with capital growth and income over the long term, through investment in listed or quoted global healthcare companies. The Company invests in a concentrated portfolio of listed or quoted equities in the global healthcare industry. The Company may also invest in American Depositary Receipts (ADRs), or convertible instruments issued by such companies and may invest in, or underwrite, future equity issues by such companies. Its portfolio includes Dental, Diagnostics, Diversified Therapeutics, Focused Therapeutics, Healthcare information technology, Healthcare Technology, Managed Care, Med-Tech, and Services. The Company's investment manager is Bellevue Asset Management (UK) Limited.
- Revenue in GBP (TTM)-19.04m
- Net income in GBP-30.45m
- Incorporated2016
- Employees0.00
- LocationBellevue Healthcare Trust plc6th Floor, 125 London Wall, BarbicanLONDON EC2Y 5ASUnited KingdomGBR
- Phone+44 20 7653 9690
- Websitehttps://www.bellevuehealthcaretrust.com/uk-en/private/
Profile
| Management group(s) | Bellevue Asset Management (UK) Ltd |
|---|---|
| AIC sector | Biotechnology & Healthcare |
| ISIN | GB00BZCNLL95 |
| Launch date | 02 Dec 2016 |
| Share type | Ordinary Share |
| Structure | Investment Trust |
| Base currency | GBP |
Objective
To provide Shareholders with capital growth and income over the long term, through investment in listed or quoted global healthcare companies. The Company may also invest in ADRs, or convertible instruments issued by such companies and may invest in, or underwrite, future equity issues by such companies.
Managed by
| Paul Major, Brett Darke |
|---|
Management & contract fees
Management fee payable monthly in arrear and is at the rate of one-twelfth of 0.95% per calendar month of the Market Capitalisation.There is no performance fee payable to Bellevue. The agreement is terminable on 12 months notice.
Peer analysis
| Company | Revenue (TTM) | Net income (TTM) |
|---|---|---|
| Chrysalis Investments Ltd | 109.41m | 103.82m |
| Henderson European Trust PLC | 76.31m | 71.73m |
| SDCL Energy Efficiency Income Trust PLC | -44.70m | -56.30m |
| Polar Capital Global Fincls Trust PLC | 125.60m | 115.76m |
| Bluefield Solar Income Fund Ltd | 925.00k | -9.60m |
| Baillie Gifford Japan Trust PLC | 72.15m | 63.76m |
| Bellevue Healthcare Trust PLC | -19.04m | -30.45m |
| Henderson Smaller Companies Inv Trst PLC | 100.37m | 93.35m |
| Molten Ventures PLC | -47.80m | -40.60m |
| Partners Group Private Equity Ltd | 51.23m | 19.18m |
| Brunner Investment Trust Plc | 109.30m | 103.52m |
| GCP Infrastructure Investments Ltd | 36.08m | 15.07m |
| Edinburgh Worldwide Investment Trust plc | -75.55m | -87.03m |
| VinaCapital Vietnam Opportunity Fund Ltd | 78.92m | 57.63m |
| Syncona Ltd | 5.65m | -17.55m |
| BlackRock Smaller Companies Trust plc | 133.64m | 125.78m |
Institutional shareholders
| Holder | Shares | % Held |
|---|---|---|
| Brewin Dolphin Ltd.as of 09 Jun 2023 | 27.26m | 6.08% |
| Evelyn Partners Investment Management LLPas of 17 Oct 2024 | 22.33m | 4.98% |
| BMO Asset Management, Inc.as of 23 Sep 2024 | 11.10m | 2.48% |
| BlackRock Investment Management (UK) Ltd.as of 30 Sep 2024 | 7.83m | 1.75% |
| Vanguard Global Advisers LLCas of 31 Oct 2024 | 6.88m | 1.53% |
| CG Asset Management Ltd.as of 31 Oct 2024 | 3.73m | 0.83% |
| Handelsbanken Wealth & Asset Management Ltd.as of 30 Jun 2024 | 2.49m | 0.56% |
| HSBC Global Asset Management (UK) Ltd.as of 07 Nov 2024 | 2.38m | 0.53% |
| Legal & General Investment Management Ltd.as of 30 Sep 2024 | 1.56m | 0.35% |
| BlackRock Advisors (UK) Ltd.as of 08 Nov 2024 | 1.54m | 0.34% |
